Release Date: 28/09/12 12:21 Summary: Lapse and Cancellation of Unlisted Options Price Sensitive: No Download Document 35.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%